ACE2 and infection: The recombinant lineage XBB, initially detected in India and projected to become dominant worldwide at the end of 2022, contained many amino acid substitutions in the spike protein significantly associated with BA.2 breakthrough infection and enhanced ACE2 binding affinity [23].